首页> 外国专利> DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells

DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells

机译:DHA和PDF,神经和视网膜色素上皮细胞的治疗成分

摘要

The combination of pigment epithelium-derived factor (PEDF) and docosahexaenoic acid (DHA) has been discovered to act synergistically to enhance cell survival and decrease apoptosis in retinal pigment epithelial (RPE) cells. PEDF and DHA synergistically protected RPE cells by confronted with oxidative stress by blocking apoptotic cell death and increasing the synthesis of the important mediator neuroprotectin D 1. Administering a composition comprising PEDF and DHA will halt or slow down the initiation and progression of macular degeneration, retinitis pigmentosa and retinal degeneration. In addition, the topical application of the combination of PEDF and DHA was found to promote cornea nerve regeneration after refractive surgery, and thus this combination could be used to prevent the complications of refractive surgery and certain diseases, e.g., neurotrophic keratitis due to Herpes virus.
机译:已发现色素上皮衍生因子(PEDF)和二十二碳六烯酸(DHA)的组合具有协同作用,以增强细胞存活并减少视网膜色素上皮(RPE)细胞的凋亡。 PEDF和DHA通过阻止凋亡性细胞死亡并增加重要介导神经保护素D 1的合成而面对氧化应激,从而协同保护RPE细胞。施用包含PEDF和DHA的组合物将阻止或减慢黄斑变性,视网膜炎的发生和发展。色素变性和视网膜变性。另外,发现局部使用PEDF和DHA的组合可促进屈光手术后的角膜神经再生,因此该组合可用于预防屈光手术的并发症和某些疾病,例如疱疹病毒引起的神经营养性角膜炎。

著录项

  • 公开/公告号US2010303887A1

    专利类型

  • 公开/公告日2010-12-02

    原文格式PDF

  • 申请/专利权人 NICOLAS G. BAZAN;

    申请/专利号US20080670986

  • 发明设计人 NICOLAS G. BAZAN;

    申请日2008-07-30

  • 分类号A61K9;A61K38/22;A61P27/02;A61P25;

  • 国家 US

  • 入库时间 2022-08-21 18:11:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号